• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 BR-MA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 BR-MA Back to Search Results
Model Number IMMULITE 2000 BR-MA
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/02/2016
Event Type  malfunction  
Manufacturer Narrative
A siemens headquarters support center (hsc) specialist reviewed the data provided by the customer.The hsc specialist informed the customer that the immulite 2000 br-ma (cancer antigen 15-3) instructions for use (ifu) states the assay is for the quantitative measurement of br-ma in human serum, as an aid in the detection of recurrence in previously treated stage ii and stage iii breast cancer patients, and in the management of metastatic breast cancer patients by monitoring disease progression or response to treatment.It is not a screening assay.The expected values section of the ifu indicates there are small percentages of samples that will recover greater than 38 u/ml (normal females 5-6%, pregnant females 10%, and females without malignant disease 26%).As noted in the ifu, ca 15-3 antigen levels in a given specimen determined with assays from different manufacturers can vary due to differences in assay methods and reagent specificity.Results reported by the laboratory to the physician must include the identity of the assay used to measure ca 15-3 antigen levels.Values obtained with different assays cannot be used interchangeably.Before changing assays, the laboratory must confirm baseline values for patients being serially monitored.The immulite br-ma assay is a sandwich immunoassay that uses murine monoclonal antibodies to capture and detect ca 15-3 in serum.It is unknown which antibodies are used on the alternate platform.The cause of the discordant, falsely elevated br-ma results on one patient sample is unknown.The br-ma assay is performing as intended.
 
Event Description
A discordant, falsely elevated br-ma (cancer antigen 15-3) result was obtained on one patient sample on an immulite 2000 xpi instrument while using kit lot 257.It is unknown if the discordant result was reported to the physician(s).The patient underwent image testing and there was no suspicion of any type of cancer.A new sample was obtained from the customer and was tested on the same instrument using kit lot 260 and the result was still elevated.The customer sent the sample to another laboratory where the sample was tested on an alternate platform.The result on the alternate platform was lower.The result obtained on the alternate platform was reported to the physician(s).There were no reports of adverse health consequences due to the discordant, falsely elevated br-ma results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMMULITE 2000 BR-MA
Type of Device
IMMULITE 2000 BR-MA
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
registration #: 3002806944
glyn rhonwy
llanberis, gwynedd, LL55 4EL
UK  LL55 4EL
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
registration #: 3002806944
glyn rhonwy
llanberis, gwynedd, LL55 4EL
UK   LL55 4EL
Manufacturer Contact
aarti aziz
511 benedict avenue
tarrytown, NY 10591
9145242683
MDR Report Key6029671
MDR Text Key57564353
Report Number2432235-2016-00623
Device Sequence Number1
Product Code MOI
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K013984
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial
Report Date 10/14/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/14/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberIMMULITE 2000 BR-MA
Device Catalogue NumberL2KBR
Device Lot Number237/240
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/20/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-